These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37295840)

  • 41. Increasing vaccination coverage among healthcare workers: Active call and mandatory laws. Data from a large general hospital in Southern Italy.
    Stefanizzi P; Di Lorenzo A; Capodiferro L; Moscara L; Noviello C; Vimercati L; De Maria L; Tafuri S
    Vaccine; 2024 Oct; 42(24):126098. PubMed ID: 39013692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association Between Influenza Vaccination and SARS-CoV-2 Infection.
    Ma'ayeh M; de Voest JA; Hughes BL; Grobman WA; Saade GR; Manuck TA; Longo M; Simhan HN; Rouse DJ; Mendez-Figueroa H; Gyamfi-Bannerman C; Bailit JL; Costantine MM; Sehdev HM; Tita ATN; Metz TD;
    Am J Reprod Immunol; 2024 Jul; 92(1):e13896. PubMed ID: 38994889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza season.
    Andrejko KL; Myers JF; Openshaw J; Fukui N; Li S; Watt JP; Murray EL; Hoover C; Lewnard JA; Jain S; Pry JM;
    Vaccine; 2023 Feb; 41(6):1190-1197. PubMed ID: 36585281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study.
    Moscara L; Venerito V; Martinelli A; Di Lorenzo A; Toro F; Violante F; Tafuri S; Stefanizzi P
    Vaccine; 2023 Aug; 41(38):5655-5661. PubMed ID: 37544827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors of seasonal influenza and COVID-19 vaccination coverage among adults in Tennessee during the COVID-19 pandemic.
    Cunningham-Erves J; George W; Sanderson M; Stewart E; Jin SW; Davis J; Brandt HM
    Front Public Health; 2024; 12():1321173. PubMed ID: 38500722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exclusive and dual influenza and COVID-19 vaccination among U.S. adults and adolescents in 2021.
    Nguyen KH; Zhao R; Chen S; Bednarczyk RA
    Ann Med; 2023 Dec; 55(1):2196436. PubMed ID: 37052255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study.
    Watkinson RE; Williams R; Gillibrand S; Sanders C; Sutton M
    PLoS Med; 2022 Mar; 19(3):e1003932. PubMed ID: 35239661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Facilitators and barriers of vaccine uptake in patients with autoimune inflammatory rheumatic disease: a scoping review.
    Neusser S; Neumann A; Zur Nieden P; Speckemeier C; Schlierenkamp S; Walendzik A; Karbach U; Andreica I; Vaupel K; Baraliakos X; Kiltz U
    RMD Open; 2022 Dec; 8(2):. PubMed ID: 36562767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.
    Walldorf J; von Arnim U; Schmelz R; Riesner-Wehner A; Michl P; Grunert PC; Stallmach A; Teich N; Reuken PA
    Inflamm Bowel Dis; 2021 Oct; 27(11):1858-1861. PubMed ID: 34181021
    [No Abstract]   [Full Text] [Related]  

  • 51. Attitudes, Perceptions and Practices of Influenza Vaccination in the Adult Population: Results of a Cross-Sectional Survey in Spain.
    Prada-García C; Fernández-Espinilla V; Hernán-García C; Sanz-Muñoz I; Martínez-Olmos J; Eiros JM; Castrodeza-Sanz J
    Int J Environ Res Public Health; 2022 Sep; 19(17):. PubMed ID: 36078854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of factors involved in the development of humoral response to vaccination against SARS-CoV-2 in patients with rheumatic pathology under biological treatment.
    Flores-Fernández E; Vázquez-Gomez I; Valls-Pascual E; Valera-Ribera C; Andújar-Brazal P; Alegre-Sancho JJ
    Reumatol Clin (Engl Ed); 2023 Dec; 19(10):565-570. PubMed ID: 38008603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination.
    Connolly CM; Ruddy JA; Boyarsky BJ; Barbur I; Werbel WA; Geetha D; Garonzik-Wang JM; Segev DL; Christopher-Stine L; Paik JJ
    Arthritis Rheumatol; 2022 Jan; 74(1):28-32. PubMed ID: 34346185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany.
    Sengler C; Eulert S; Minden K; Niewerth M; Horneff G; Kuemmerle-Deschner J; Siemer C; Berendes R; Girschick H; Hühn R; Borte M; Hospach A; Emminger W; Armann J; Klein A; Kallinich T
    RMD Open; 2021 Jul; 7(2):. PubMed ID: 34312307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases.
    Hasseli R; Richter JG; Hoyer BF; Lorenz HM; Pfeil A; Regierer AC; Schmeiser T; Strangfeld A; Voll RE; Krause A; Reckert S; Gräßler A; Saar P; Kapelle A; Backhaus M; Blank N; Henes J; Osiek S; Knothe A; Hoese G; Brandt-Jürgens J; Maltzahn A; Specker C; Müller-Ladner U; Schulze-Koops H; ;
    RMD Open; 2023 Apr; 9(2):. PubMed ID: 37068915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine.
    Moutsopoulos HM
    J Autoimmun; 2021 Jul; 121():102649. PubMed ID: 33984571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence, risk factors, and whole-genome sequence of SARs-CoV-2 and influenza virus among the Egyptian pilgrims returning from Umrah mass gathering in Saudi Arabia, April-May 2022.
    Kandeel A; Fahim M; Deghedy O; Alim W; Roshdy WH; Khalifa MK; El Shesheny R; Kandeil A; Naguib A; Elguindy N; Abdel Fattah M; Afifi S; Mohsen A; Abdelghaffar K
    J Infect Public Health; 2022 Nov; 15(11):1290-1296. PubMed ID: 36274370
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acceptance of seasonal influenza vaccination and associated factors among pregnant women in the context of COVID-19 pandemic in China: a multi-center cross-sectional study based on health belief model.
    Wang R; Tao L; Han N; Liu J; Yuan C; Deng L; Han C; Sun F; Chi L; Liu M; Liu J
    BMC Pregnancy Childbirth; 2021 Nov; 21(1):745. PubMed ID: 34732157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influenza and COVID-19 co-infection and vaccine effectiveness against severe cases: a mathematical modeling study.
    Liang J; Wang Y; Lin Z; He W; Sun J; Li Q; Zhang M; Chang Z; Guo Y; Zeng W; Liu T; Zeng Z; Yang Z; Hon C
    Front Cell Infect Microbiol; 2024; 14():1347710. PubMed ID: 38500506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Knowledge, attitudes, and practices towards influenza among Chinese adults during the epidemic of COVID-19: a cross-sectional online survey.
    Jiang M; Feng L; Wang W; Gong Y; Ming WK; Hayat K; Li P; Gillani AH; Yao X; Fang Y
    Hum Vaccin Immunother; 2021 May; 17(5):1412-1419. PubMed ID: 33222609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.